To view journal scope & editors or submit a manuscript, please select a specific journal:
US Oncology subscribes to CIG Media
CIG Media Group, publisher of the largest portfolio of peer-reviewed, tumor-specific, clinical oncology/ hematology journals, now counts US Oncology among the respected organizations that subscribe to its full package of journals. Since publishing its inaugural issue more than a decade ago, CIG Media Group has attracted high readership and interest among academic, government, and corporate institutions. US Oncology will make all CIG journal articles available to the physicians and health care professionals throughout the US Oncology network via the company’s Oncology Portal.
“With this new agreement in place, the more than 1,300 members of US Oncology have our clinically relevant and tumor-specific journals at their fingertips when they need it. Our peer-reviewed content is perfectly suited to enhance the abilities of US Oncology physicians in providing optimal care for the over 720,000 cancer patients they treat each year,” said Jasper Simons, VP, Publisher, CIG Media Group, LP.
Today, CIG continues to strengthen its strategic partnerships with the world’s leading cancer research and treatment institutions into 2010 and beyond. Among others, the National Institutes of Health Library, M. D. Anderson Cancer Center, Roswell Park Cancer Center, Memorial Sloan-Kettering Cancer Center, Washington University School of Medicine, City of Hope – Graff Medical Library, Vanderbilt University Eskind Biomedical Library, Cross Cancer Institute in Canada, and the Oncology Nursing Society continue to provide their end-users with subscriptions to the full package of CIG’s peer-reviewed, tumor-specific clinical oncology/hematology journals.
Pricing and online terms and conditions for all CIG journals, along with a simple and concise site license, can be obtained from the editorial office or at the corporate website at www.cigjournals.com.
Free online trials for institutions are available.
About CIG Media Group, LP
Dallas-based CIG Media Group, LP, is a subsidiary of Medical Media Holdings, LLC. Founded in 1996, CIG Media Group, LP, is the premier publisher of peer-reviewed tumor-specific medical oncology journals: Clinical Lung Cancer; Clinical Colorectal Cancer; Clinical Breast Cancer; Clinical Lymphoma, Myeloma & Leukemia; and Clinical Ovarian Cancer. All of the company’s established journals are indexed in PubMed. Each year, CIG Media Group, LP, also publishes multiple tumor-specific journal supplements that provide oncology professionals with opportunities to earn ACCME-approved continuing medical education credits. For more information about CIG Media Group, LP, and its clinical oncology journals, please visit www.cigjournals.com.
About US Oncology
From its genesis in physician practice management, US Oncology has expanded into an organization that touches nearly every aspect of cancer care, from research, specialty pharmacy, and drug distribution to billing and reimbursement, electronic medical records (EMR), continuing education, and the use of evidence-based medicine pathways. Headquartered in the Houston, Texas area, US Oncology works closely with providers, payers, biotechnology and pharmaceutical companies, medical equipment manufacturers, and legislators to increase patient access to, and advance the delivery of, high-quality cancer care in America through our clinical insight and expertise.